Metraipolis › archive › dc_04e75ecf862b

Advancements and challenges in brain cancer therapeutics — Europe PMC PMID:39713205

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39713205
DOI
10.1002/exp.20230177
License (as archived)
solo-consultazione
Archived
2026-10-08T02:36:57.679Z
SHA-256 of the archived text
c84c9de84964962c48bad44cee71eb81879384897f81340589153c3e2df44859
Stable URL of this page
https://metraipolis.com/documento/dc_04e75ecf862b

How to cite

Advancements and challenges in brain cancer therapeutics — Europe PMC PMID:39713205 — Europe PMC (en), https://europepmc.org/article/MED/39713205 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04e75ecf862b (Metraipolis archive dc_04e75ecf862b, sha256 c84c9de84964962c48bad44cee71eb81879384897f81340589153c3e2df44859)
BibTeX
@misc{dc04e75ecf862b,
  title = {Advancements and challenges in brain cancer therapeutics — Europe PMC PMID:39713205},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39713205},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04e75ecf862b; sha256 c84c9de84964962c48bad44cee71eb81879384897f81340589153c3e2df44859},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39713205. Agents can read the archived copy with the MCP tool read_document.